The North America Viral Vector Production Market would witness market growth of 18% CAGR during the forecast period (2023-2030).
Gene therapy involves introducing, altering, or replacing genes to treat or prevent diseases. Viral vectors are pivotal in delivering therapeutic genes into target cells, addressing genetic disorders, and offering potential cures for previously incurable conditions. For example, lentiviral vectors have shown assurance in feasting genetic disorders like sickle cell anemia and beta-thalassemia. Viral vectors enhance the immune system's ability to target and destroy cancer cells in cancer treatment. Oncolytic viruses, for instance, are designed to infect and destroy cancer cells while limiting healthy tissues selectively. This application shows promise in various cancer types and is under active research and development.
Viral vectors play a crucial role in neuroscience research by facilitating the delivery of genes into the central nervous system. This enables the study of neuronal function, neurodegenerative diseases, and the development of potential therapies for conditions like Parkinson's and Alzheimer's disease. As the demand for viral vectors escalates, there is a growing emphasis on optimizing production processes to achieve scalability and cost-effectiveness. Innovations in bioprocessing technologies, such as single-use systems and high-density cell culture platforms, are streamlining the manufacturing of viral vectors, ensuring a robust and reliable supply chain.
North America, particularly the United States, is a biopharmaceutical research and development hub. The region sees substantial investments from both public and private sectors in developing advanced therapies, including gene therapies and vaccines, boosting the demand for viral vectors. North America has a well-established biotechnology and pharmaceutical infrastructure, with numerous companies specializing in viral vector production. Thus, the above aspects will expand the market growth across the region in the upcoming years.
The US market dominated the North America Viral Vector Production Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,164.5 Million by 2030. The Canada market is experiencing a CAGR of 20.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 19.6% during (2023 - 2030).
Free Valuable Insights: The Viral Vector Production Market is Predict to reach USD 3.9 Billion by 2030, at a CAGR of 19.1%
Based on Type, the market is segmented into Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others. Based on Indication, the market is segmented into Cancer, Genetic Disorders, Infectious Diseases, and Others. Based on Application, the market is segmented into Gene Therapy, and Vaccinology. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Andelyn Biosciences, Inc.
- Charles River Laboratories International, Inc.
- Danaher Corporation
- FinVector Oy (Ferring Ventures S/A)
- Thermo Fisher Scientific, Inc.
- Novartis AG
- Takara Bio Inc. (Takara Holdings Inc.)
- Avid Bioservices, Inc.
- Oxford Biomedica plc
- Lonza Group Ltd.
North America Viral Vector Production Market Report Segmentation
By Type
- Adeno-Associated Viral Vectors
- Lentiviral Vectors
- Adenoviral Vectors
- Retroviral Vectors
- Others
By Indication
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
By Application
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Viral Vector Production Market, by Type
1.4.2 North America Viral Vector Production Market, by Indication
1.4.3 North America Viral Vector Production Market, by Application
1.4.4 North America Viral Vector Production Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Viral Vector Production Market
Chapter 5. North America Viral Vector Production Market, by Type
5.1 North America Adeno-Associated Viral Vectors Market, by Country
5.2 North America Lentiviral Vectors Market, by Country
5.3 North America Adenoviral Vectors Market, by Country
5.4 North America Retroviral Vectors Market, by Country
5.5 North America Others Market, by Country
Chapter 6. North America Viral Vector Production Market, by Indication
6.1 North America Cancer Market, by Country
6.2 North America Genetic Disorders Market, by Country
6.3 North America Infectious Diseases Market, by Country
6.4 North America Others Market, by Country
Chapter 7. North America Viral Vector Production Market, by Application
7.1 North America Gene Therapy Market, by Country
7.2 North America Vaccinology Market, by Country
Chapter 8. North America Viral Vector Production Market, by Country
8.1 US Viral Vector Production Market
8.1.1 US Viral Vector Production Market, by Type
8.1.2 US Viral Vector Production Market, by Indication
8.1.3 US Viral Vector Production Market, by Application
8.2 Canada Viral Vector Production Market
8.2.1 Canada Viral Vector Production Market, by Type
8.2.2 Canada Viral Vector Production Market, by Indication
8.2.3 Canada Viral Vector Production Market, by Application
8.3 Mexico Viral Vector Production Market
8.3.1 Mexico Viral Vector Production Market, by Type
8.3.2 Mexico Viral Vector Production Market, by Indication
8.3.3 Mexico Viral Vector Production Market, by Application
8.4 Rest of North America Viral Vector Production Market
8.4.1 Rest of North America Viral Vector Production Market, by Type
8.4.2 Rest of North America Viral Vector Production Market, by Indication
8.4.3 Rest of North America Viral Vector Production Market, by Application
Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
TABLE 1 North America Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 2 North America Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 3 North America Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 4 North America Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 5 North America Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 12 North America Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 13 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 North America Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 16 North America Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 17 North America Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 22 North America Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 26 North America Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 27 North America Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 28 North America Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 29 North America Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 30 North America Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 31 North America Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 32 North America Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 33 US Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 34 US Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 35 US Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 36 US Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 37 US Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 38 US Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 39 US Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 40 US Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 41 Canada Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 42 Canada Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 43 Canada Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 44 Canada Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 45 Canada Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 46 Canada Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 47 Canada Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 48 Canada Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 49 Mexico Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 50 Mexico Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 51 Mexico Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 52 Mexico Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 53 Mexico Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 54 Mexico Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 55 Mexico Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 56 Mexico Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 57 Rest of North America Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 58 Rest of North America Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 59 Rest of North America Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 60 Rest of North America Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 61 Rest of North America Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 62 Rest of North America Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 63 Rest of North America Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 64 Rest of North America Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 65 Key Information – Andelyn Biosciences, Inc.
TABLE 66 key information – Charles River Laboratories International, Inc.
TABLE 67 Key Information – Danaher Corporation
TABLE 68 Key Information – FinVector Oy
TABLE 69 Key Information – Thermo Fisher Scientific, Inc.
TABLE 70 Key Information – Novartis AG
TABLE 71 Key Information – Takara Bio Inc.
TABLE 72 Key Information – Avid Bioservices, Inc.
TABLE 73 Key Information – Oxford Biomedica PLC
TABLE 74 Key Information –Lonza Group Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Viral Vector Production Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Viral Vector Production Market
FIG 4 Porter’s Five Forces Analysis – viral vector production market
FIG 5 North America Viral Vector Production Market share, by Type, 2022
FIG 6 North America Viral Vector Production Market share, by Type, 2030
FIG 7 North America Viral Vector Production Market, by Type, 2019 - 2030, USD Million
FIG 8 North America Viral Vector Production Market share, by Indication, 2022
FIG 9 North America Viral Vector Production Market share, by Indication, 2030
FIG 10 North America Viral Vector Production Market, by Indication, 2019 - 2030, USD Million
FIG 11 North America Viral Vector Production Market share, by Application, 2022
FIG 12 North America Viral Vector Production Market share, by Application, 2030
FIG 13 North America Viral Vector Production Market, by Application, 2019 - 2030, USD Million
FIG 14 North America Viral Vector Production Market share, by Country, 2022
FIG 15 North America Viral Vector Production Market share, by Country, 2030
FIG 16 North America Viral Vector Production Market, by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Andelyn Biosciences, Inc.
FIG 18 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 19 Swot Analysis: Charles River Laboratories International, Inc.
FIG 20 SWOT Analysis: Danaher Corporation
FIG 21 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 22 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Recent strategies and developments: Oxford Biomedica plc
FIG 25 Swot Analysis: Lonza Group Ltd.